IM Cannabis (IMCC) Cash from Discontinued Operations (2020 - 2026)

IM Cannabis' (IMCC) quarterly Cash from Discontinued Operations came in at 135.63 in Q1 2026, down 95.64% year-on-year from 3110.34 in Q1 2025, and down 95.64% quarter-over-quarter from 3110.34 in Q1 2025.

IM Cannabis (IMCC) Cash from Discontinued Operations (2020 - 2026) Analysis & Trends

IM Cannabis' Cash from Discontinued Operations history runs 4 years deep, the most recent figure standing at 135.63 for Q1 2026.

  • On a quarterly basis, Cash from Discontinued Operations fell 95.64% year-over-year to 135.63 in Q1 2026; TTM through Mar 2026 was 14764381.13, a N/A change from a year earlier, with the FY2020 full-year figure at 5911372.62, changed N/A from the prior year.
  • Cash from Discontinued Operations declined to 135.63 in Q1 2026 per IMCC's latest filing, from 3110.34 in the prior quarter.
  • Across five years, Cash from Discontinued Operations topped out at 3110.34 in Q1 2025 and bottomed at 135.63 in Q1 2026.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Discontinued Operations (Qtr)
1 Haleon 89.42 Bn 87.55 Bn - -
2 Teva Pharmaceutical Industries 35.86 Bn 32.12 Bn 1.97 Bn -
3 Zoetis 32.46 Bn 30.52 Bn 1.62 Bn -
4 Takeda Pharmaceutical 27.52 Bn 23.46 Bn 4.39 Bn -
5 United Therapeutics 23.15 Bn 20.99 Bn 648.10 Mn -
6 RedHill Biopharma 21.17 Bn 21.17 Bn - -
7 Viatris 20.32 Bn 18.51 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.74 Bn 16.42 Bn 800.70 Mn -
9 Elanco Animal Health 12.63 Bn 12.20 Bn 785.00 Mn -
10 IM Cannabis 526,284.79 -205,837.72 1.03 Mn 135.63

Historic Data

Download Data
DateValue
Mar 31, 2026 135.63
Mar 31, 2026 135.63
Mar 31, 2025 3,110.34
Mar 31, 2025 3,110.34
Jun 30, 2021 12.38 Mn
Jun 30, 2021 12.38 Mn
Jun 30, 2020 2.38 Mn
Jun 30, 2020 2.38 Mn